Ezetimibe

Tsanangudzo Pfupi

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP
Ezetimibe Hyperlipidemia Mumba/USP 24511  


Product Detail

Product Tags

PRODUCT DETAIL

Background

Ezetimibe ine simba uye novel inhibitor yekunyudza cholesterol [1].

Cholesterol i lipid molecule uye inodikanwa kuvaka nekuchengetedza membrane hunhu hwekuvimbika uye fluidity.Zvakare, inoshanda seyakatangira vhitamini D, bile acids uye steroid mahomoni.

Mumasero eCaco-2 akasiyana-siyana akaiswa necarotenoid (1 μM), ezetimibe (10 mg / L) inhibited carotenoid kutakura ne 50% inhibition ye ɑ-carotene uye β-carotene.Zvakare, yairambidza kutakurwa kweβ-cryptoxanthin, lycopene uye lutein:zeaxanthin (1: 1).Panguva imwecheteyo, ezetimibe inhibited cholesterol kutakura ne31%.Ezetimibe yakaderedza kutaura kweiyo yepamusoro receptors SR-BI, ATP inosunga kaseti inotakura, subfamily A (ABCA1), Niemann-Pick rudzi C1 Se 1 protein (NPC1L1) uye retinoid acid receptor (RAR) γ, sterol-regulatory chinhu chinosunga mapuroteni SREBP -1 uye SREBP-2, uye chiropa X receptor (LXR) β [3].

Mu apolipoprotein E kugogodza (apoE-/-) mbeva, ezetimibe (3 mg/kg) yakadzivisa kutorwa kwecholesterol ne90%.Ezetimibe yakaderedza plasma cholesterol, yakawedzera HDL mazinga, uye inhibisa kufambira mberi kweatherosclerosis [1].Muchikamu chechitatu chekuedzwa kwevanhu, Ezetimibe (10 mg) yakaderedza zvakanyanya mazinga eLDL cholesterol, cholesterol yakazara uye triglycerides uye yakawedzera huwandu hweHDL cholesterol [2].

References:
[1].Davis HR Jr, Compton DS, Hoos L, et al.Ezetimibe, ine simba cholesterol absorption inhibitor, inhibitor kukura kweatherosclerosis muApoE knockout mice.Arterioscler Thromb Vasc Biol, 2001, 21(12): 2032-2038.
[2].Clader JW.Kuwanikwa kwezetimibe: maonero kubva kunze kwekugamuchira.J Med Chem, 2004, 47(1): 1-9.
[3].Panguva A, Dawson HD, Harrison EH.Kutakura kweCarotenoid kwakadzikira uye kutaura kweiyo lipid transporters SR-BI, NPC1L1, uye ABCA1 inoderedzwa muCaco-2 masero anobatwa nezetimibe.J Nutr, 2005, 135(10): 2305-2312.

Tsanangudzo

Ezetimibe (SCH 58235) ine simba cholesterol absorption inhibitor.Ezetimibe is an Niemann-Pick C1-like1 (NPC1L1) inhibitor, uye ine simba Nrf2 activator.

In Vitro

Ezetimibe (Eze) inoshanda senge ine simba Nrf2 activator pasina kukonzera cytotoxicity.Ezetimibe inowedzera transactivation yeNrf2, sezvakaratidzwa ne luciferase reporter assay.Ezetimibe inokwidzawo Nrf2 chinangwa chemajini, kusanganisira GSTA1, heme oxygenase-1 (HO-1) uye Nqo-1 muHepa1c1c7 uye MEF masero.Ezetimibe inokwirisa Nrf2 chinangwa chemajini muNrf2 +/+ MEF maseru, nepo induction iyi yakavharwa zvachose muNrf2-/- MEF maseru.Zvakatorwa pamwechete, Ezetimibe inoita senge inoveli Nrf2 inducer nenzira yakazvimiririra yeROS[1].Munhu huh7 hepatocytes akaiswa kare neEzetimibe (10μM, 1 h) uye yakanyudzwa nepalmitic acid (PA, 0.5 mM, 24 h) kuti iite hepatic steatosis.Kurapa kweEzetimibe kunoderedza zvakanyanya PA-yakawedzera triglycerides (TG) mazinga, izvo zvinoenderana nekudzidza kwedu mhuka.Kurapwa kwePA kwakakonzera kudzikira kunosvika makumi maviri muzana muRNA kutaura kweATG5, ATG6, uye ATG7, iyo yakanga yawedzerwa neEzetimibe kurapwa.Mukuwedzera, kurapwa kweEzetimibe kwakawedzera zvakanyanya kuderedzwa kwePA muLC3 protein yakawanda [2].

MCE haina kuzvimiririra yakasimbisa chokwadi chenzira idzi.Ndedzekureva chete.

Kutonga kweEzetimibe (Eze) kunoderedza huremu hwechiropa hwembeva dzakadyiswa methionine- uye choline-deficient (MCD) kudya.Izvi zvinoenderana nerubatsiro rweEzetimibe pane hepatic steatosis.Chiropa histology inoratidza yakadanwa akawanda macrovesicular mafuta madonhwe mumakonzo paMCD chikafu, asi kurapwa kweEzetimibe kunoderedza huwandu uye saizi yemadonhwe iwayo.Uyezve, hepatic fibrosis mumakonzo akadyisa kudya kweMCD inonyanya kudzikiswa neEzetimibe[1].Ropa uye chiropa lipid mazinga anosanganisira TG, emahara fatty acids (FFA), uye yakazara cholesterol (TC) akadzikira zvakanyanya mumakonzo eEzetimibe anorapwa OLETF.Uyezve, makonzo eOLETF anoratidza akakwira serum mazinga eglucose, insulin, HOMA-IR, TG, FFA, uye TC pane LETF mhuka, iyo yakanyanya kuderedzwa neEzetimibe.Pamusoro pezvo, ongororo yenhoroondo yakaratidza kuti OLETF yekudzora makonzo yakaratidza madonhwe makuru elipid muhepatocytes kupfuura zera-rinofananidzwa LETO zvidzoreso, izvo zvakadzikiswa nekutonga kweEzetimibe[2].

Storage

Upfu

-20°C

3 years
 

4°C

2 years
In solvent

-80°C

6 mwedzi
 

-20°C

1 mwedzi

Chimiro chemakemikari

Ezetimibe

CERTIFICATE

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

HUNHU MANAGEMENT

Quality management1

Proposal18Quality Consistency Evaluation mapurojekiti akatenderwa4,uye6mapurojekiti ari pasi pekubvumidzwa.

Quality management2

Yepamberi yepasirese yemhando manejimendi system yakaisa hwaro hwakasimba hwekutengesa.

Quality management3

Kutariswa kwemhando yepamusoro kunofamba kuburikidza nehupenyu hwese kutenderera kwechigadzirwa kuti ive nechokwadi chemhando nekurapa.

Quality management4

Professional Regulatory Affairs timu inotsigira zvinodiwa zvemhando panguva yekushandisa uye kunyoreswa.

KUTUNGAMIRIRA KWEKUGARA

cpf5
cpf6

Korea Countec Bottled Packaging Line

cpf7
cpf8

Taiwan CVC Bottled Packaging Line

cpf9
cpf10

Italy CAM Board Packaging Line

cpf11

German Fette Compacting Machine

cpf12

Japan Viswill Tablet Detector

cpf14-1

DCS Control Room

PARTNER

Kudyidzana kwenyika dzose
International cooperation
Kushandira pamwe kwemumba
Domestic cooperation

  • Zvakapfuura:
  • Zvinotevera:

  • Nyora meseji yako pano uye utumire kwatiri